- Home
- EAD vs ABSI Comparison
EAD vs ABSI Comparison
Compare EAD & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EAD
- ABSI
- Stock Information
- Founded
- EAD 2003
- ABSI 2011
- Country
- EAD United States
- ABSI United States
- Employees
- EAD N/A
- ABSI N/A
- Industry
- EAD Finance/Investors Services
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- EAD Finance
- ABSI Health Care
- Exchange
- EAD Nasdaq
- ABSI Nasdaq
- Market Cap
- EAD 400.1M
- ABSI 353.8M
- IPO Year
- EAD N/A
- ABSI 2021
- Fundamental
- Price
- EAD $6.84
- ABSI $2.65
- Analyst Decision
- EAD
- ABSI Strong Buy
- Analyst Count
- EAD 0
- ABSI 5
- Target Price
- EAD N/A
- ABSI $8.40
- AVG Volume (30 Days)
- EAD 178.9K
- ABSI 2.9M
- Earning Date
- EAD 01-01-0001
- ABSI 05-13-2025
- Dividend Yield
- EAD 8.91%
- ABSI N/A
- EPS Growth
- EAD N/A
- ABSI N/A
- EPS
- EAD N/A
- ABSI N/A
- Revenue
- EAD N/A
- ABSI $4,815,000.00
- Revenue This Year
- EAD N/A
- ABSI $145.79
- Revenue Next Year
- EAD N/A
- ABSI $99.29
- P/E Ratio
- EAD N/A
- ABSI N/A
- Revenue Growth
- EAD N/A
- ABSI N/A
- 52 Week Low
- EAD $5.69
- ABSI $2.01
- 52 Week High
- EAD $6.81
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- EAD 61.58
- ABSI 40.44
- Support Level
- EAD $6.68
- ABSI $2.56
- Resistance Level
- EAD $6.84
- ABSI $2.84
- Average True Range (ATR)
- EAD 0.06
- ABSI 0.20
- MACD
- EAD 0.00
- ABSI -0.01
- Stochastic Oscillator
- EAD 100.00
- ABSI 8.26
About EAD Allspring Income Opportunities Fund
Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.